All Therapeutic Areas

Therapeutic Area

Immunology & Inflammation

30 intermediates

Request a Quote →

Area Overview

Immunology & Inflammation Portfolio

Catalog programs in this area include JAK and TYK2 pathway modulators, immune-mediated dermatology candidates, inflammatory-disease programs and other targeted approaches to immune regulation.

Classification is based on terminal APIs in the product catalog; product counts update with the catalog.

Representative Terminal APIs

Lcotrokinra(JNJ-2113) Tofacitinib Belumosudil Abrocitinib Ruxolitinib

30 catalog intermediates

Intermediates for this Area

E-01

3-Aminocyclobutanone hydrochloride

3-氨基环丁酮盐酸盐

Application

Abrocitinib

CAS No. 1035374-20-9

C₄H₈ClNO

E-02

3-Oxocyclobutanecarboxylic acid

3-氧代环丁烷甲酸

Application

Abrocitinib

CAS No. 23761-23-1

C₅H₆O₃

E-03

Tert-butyl (3-oxocyclobutyl)carbamate

叔丁基(3-氧代环丁基)氨基甲酸酯

Application

Abrocitinib

CAS No. 154748-49-9

C₉H₁₅NO₃

E-07

2-(1-(Ethylsulfonyl)azetidin-3-ylidene) acetonitrile

2-(1-(乙基磺酰基)氮杂环丁-3-亚基)乙腈

Application

Baricitinib

CAS No. 1187595-85-2

C₇H₁₀N₂O₂S

E-08

1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-(1-乙氧乙基)-4-(4,4,5,5-四甲基-1,3,2-二氧杂硼硼烷-2-基)-1H-吡唑

Application

Baricitinib / Ruxolitinib

CAS No. 1029716-44-6

C₁₃H₂₃BN₂O₃

E-09

4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-D] pyrimidine

4-氯-7-[2-(三甲基硅基)乙氧基]甲基-7H-吡咯并[2,3-d]嘧啶

Application

Baricitinib / Tofacitinib

CAS No. 941685-26-3

C₁₂H₁₈ClN₃OSi

E-10

1-Boc-5-aminoindazole

1-Boc-5-氨基吲唑

Application

Belumosudil

CAS No. 129488-10-4

C₁₂H₁₅N₃O₂

E-11

2-bromo-N-isopropylacetamide

2-溴-N-异丙基乙酰胺

Application

Belumosudil

CAS No. 75726-96-4

C₅H₁₀BrNO

E-12

N-isopropyl-2-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)phenoxy)acetamide

N-异丙基-2-(3-(4-氧代-3,4-二氢喹唑啉-2-基)苯氧基)乙酰胺

Application

Belumosudil

CAS No. 2121561-39-3

C₁₉H₁₉N₃O₃

E-13

Phenol, 3-(4-chloro-2-quinazolinyl)-, 1-acetate

3-(4-氯-2-喹唑啉基)苯酚乙酸酯

Application

Belumosudil

CAS No. 911417-24-8

C₁₆H₁₁ClN₂O₂

E-14

Brepocitinib

布雷波替尼

Application

Brepocitinib

CAS No. 1883711-97-4

C₁₇H₁₅ClN₆O₂

E-18

Deucravacitinib

氘可来昔替尼

Application

Deucravacitinib

CAS No. 1609392-27-9

C₂₀H₂₂N₈O₃

E-24

4-aminooxane-4-carboxylic acid

4 -氨基四氢吡喃-4-羧酸

Application

Lcotrokinra(JNJ-2113)

CAS No. 39124-20-4

C₆H₁₁NO₃

E-25

7-Methyl-L-tryptophan

L-7-甲基色氨酸

Application

Lcotrokinra(JNJ-2113)

CAS No. 33468-36-9

C₁₂H₁₄N₂O₂

E-27

N-Cbz-L-Glutamic acid 5-tert-butyl ester

N-苄氧羰基-L-谷氨酸-γ-叔丁酯

Application

Lcotrokinra(JNJ-2113)

CAS No. 3886-08-6

C₁₇H₂₃NO₆

E-28

N-Fmoc-7-methyl-L-tryptophan

N-芴甲氧羰基- 7-甲基-L-色氨酸

Application

Lcotrokinra(JNJ-2113)

CAS No. 1808268-53-2

C₂₇H₂₄N₂O₄

E-29

Z-Tyr-Ome

L-酪氨酸甲酯

Application

Lcotrokinra(JNJ-2113)

CAS No. 13512-31-7

C₁₈H₁₉NO₅

E-31

2-(Trimethylsilyl)ethoxymethyl chloride

2-(三甲基硅基)乙氧基甲基氯

Application

Ruxolitinib

CAS No. 76513-69-4

C₆H₁₅ClOSi

E-32

3-Cyclopentyl-acrylonitrile

3-环戊基丙烯腈

Application

Ruxolitinib

CAS No. 591769-05-0

C₈H₁₁N

E-33

Pyrazole-4-boronic acid pinacol ester

吡唑-4-硼酸频哪酯

Application

Ruxolitinib

CAS No. 269410-08-4

C₉H₁₅BN₂O₂

E-34

(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

(3R,4R)-1-苄基-N,4-二甲基哌啶-3-胺二盐酸盐

Application

Tofacitinib

CAS No. 1062580-52-2

C₁₄H₂₄Cl₂N₂

E-35

1-Benzyl-N,4-dimethylpiperidin-3-aminedihydrochloride

1-苄基-N,4-二甲基哌啶-3-胺二盐酸盐

Application

Tofacitinib

CAS No. 1228879-37-5

C₁₄H₂₄Cl₂N₂

E-36

4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE

4-氯-7-对甲苯磺酰基-7H-吡咯并[2,3-d]嘧啶

Application

Tofacitinib

CAS No. 479633-63-1

C₁₃H₁₀ClN₃O₂S

E-37

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine

4-氯-7H-吡咯并[2,3-d]嘧啶

Application

Tofacitinib

CAS No. 3680-69-1

C₆H₄ClN₃

E-38

N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-d]嘧啶-4-胺

Application

Tofacitinib

CAS No. 477600-74-1

C₁₃H₁₉N₅

E-39

(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidine carboxylic acid phenylmethyl ester

(3R,4S)-3-(2-溴乙酰基)-4-乙基-1-吡咯烷甲酸苄酯

Application

Upadacitinib

CAS No. 1428243-26-8

C₁₆H₂₀BrNO₃

E-40

tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate

叔丁基5-对甲苯磺酰基-5H-吡咯并[2,3-b]吡嗪-2-基氨基甲酸酯

Application

Upadacitinib

CAS No. 1201187-44-1

C₁₈H₂₀N₄O₄S

E-41

(S)-4-(tert-butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid

(S)-4-(叔丁氧基羰基)-1,4-氧氮杂环庚烷-2-羧酸

Application

Brensocatib

CAS No. 1273567-44-4

C₁₁H₁₉NO₅

E-42

(S)-tert-butyl (1-cyano-2-(4-iodophenyl)ethyl)carbamate

(S)-(1-氰基-2-(4-碘苯基)乙基)氨基甲酸

Application

Brensocatib

CAS No. 1159489-37-8

C₁₄H₁₇IN₂O₂

Need intermediates for this therapeutic area?

Ready to source? Our team responds to every inquiry within 24 hours.

Request a Quote →